Joseph Pichler to president, succeeding William Kagler, who said he was leaving Kroger "due to personal differences over the management of the company".
You may also be interested in...
The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Licensing agreements and bolt-on acquisitions to strengthen its R&D pipeline are still in Bayer’s sights as the COVID-19 pandemic and currency devaluations have led to the need for job cuts and substantial cost savings at the big pharma company.